Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$3.02 - $4.56 $386,451 - $583,515
-127,964 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$3.92 - $7.48 $432,415 - $825,118
110,310 Added 624.84%
127,964 $571,000
Q4 2021

Feb 14, 2022

BUY
$6.7 - $11.38 $38,391 - $65,207
5,730 Added 48.05%
17,654 $127,000
Q3 2021

Nov 15, 2021

SELL
$10.11 - $17.56 $58,536 - $101,672
-5,790 Reduced 32.69%
11,924 $128,000
Q2 2021

Aug 16, 2021

SELL
$14.9 - $20.82 $81,279 - $113,573
-5,455 Reduced 23.54%
17,714 $307,000
Q1 2021

May 17, 2021

SELL
$12.57 - $21.22 $9,352 - $15,787
-744 Reduced 3.11%
23,169 $492,000
Q4 2020

Feb 16, 2021

SELL
$8.73 - $14.56 $95,418 - $159,140
-10,930 Reduced 31.37%
23,913 $316,000
Q3 2020

Nov 16, 2020

BUY
$8.56 - $11.6 $298,256 - $404,178
34,843 New
34,843 $307,000

Others Institutions Holding ICAD

About ICAD INC


  • Ticker ICAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 25,333,900
  • Market Cap $42.8M
  • Description
  • iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. It operates through two segments, Cancer Detection and Cancer Therapy. The company offers PowerLook platform, which hosts the AI algorithm solutions and manages the communications between imaging acquisition systems, an...
More about ICAD
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.